Literature DB >> 1192368

Ataxia-telangiectasia with ovarian gonadoblastoma and contralateral dysgerminoma.

C I Goldsmith, W R Hart.   

Abstract

Although neoplasms are unusually frequent in patients with ataxia-telangiectasia, the occurrence of primary tumors of the ovary in such patients is exceedingly rare. This report describes a 17-year-old phenotypic female with ataxia-telangiectasia, who was found to harbor an ovarian gonadoblastoma and a contralateral dysgerminoma. The latter tumor has occurred in only one other patient with ataxia-telangiectasia, while an association with gonadoblastoma has never been documented previously. Additional unusual features rarely encountered in patients with gonadoblastoma included origin of the tumor within a histologically proven ovary, and a 46,XX karyotype. The possibility that the dysgerminoma also arose from a gonadoblastoma is discussed.

Entities:  

Mesh:

Year:  1975        PMID: 1192368     DOI: 10.1002/1097-0142(197511)36:5<1838::aid-cncr2820360540>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Astrocytoma linked to familial ataxia-telangiectasia.

Authors:  K Miyagi; J Mukawa; N Kinjo; K Horikawa; S Mekaru; S Nakasone; H Koga; Y Higa; M Naito
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Ataxia-telangiectasia with renal cell carcinoma and hepatoma.

Authors:  F Yoshitomi; Y Zaitsu; K Tanaka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

Review 3.  Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.

Authors:  L Taramasso; S Boisson-Dupuis; M L Garrè; E Bondi; A Cama; P Nozza; G Morana; J L Casanova; M G Marazzi
Journal:  J Clin Immunol       Date:  2014-09-14       Impact factor: 8.317

4.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.